Get the Stockscreener App
2.79
2.79%
-0.08
Aditxt Inc stock is traded at $2.79, with a volume of 68,631.
It is down -2.79% in the last 24 hours and down -91.60% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$2.87
Open:
$2.82
24h Volume:
68,631
Relative Volume:
0.81
Market Cap:
$1.56M
Revenue:
$212.10K
Net Income/Loss:
$-40.19M
P/E Ratio:
-0.000525
EPS:
-5313.2836
Net Cash Flow:
$-13.92M
1W Performance:
-42.35%
1M Performance:
-91.60%
6M Performance:
-98.58%
1Y Performance:
-99.97%
1-Day Range:
$2.6301
$2.8699
1-Week Range:
$2.6301
$4.8519
52-Week Range:
$2.6301
$11,941.28
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
2.79 | 1.44M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aditxt Inc Stock (ADTX) Latest News
Aditxt Stock Plummets -55% With 7-Day Losing Streak - Trefis
Aditxt Delays 10-Q Filing Due to Time Constraints - MSN
Aditxt : Audit Committee Charter (Aditxt Audit Committee Charter Effective 11.19.25) - MarketScreener
Aditxt Inc. (ADTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Aditxt Inc. stock deliver strong dividend growthJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Can Aditxt Inc. stock beat market expectations this quarter2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Will Aditxt Inc. stock gain from lower inflation2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing - The Globe and Mail
Aditxt, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Aditxt Announces Strategic Shift to bitXbio Strategy - TipRanks
Aditxt, Inc. Announces Strategic Transition to bitXbio - TradingView
[8-K] Aditxt, Inc. Reports Material Event | ADTX SEC FilingForm 8-K - Stock Titan
Aditxt provides updates on its growth vision for Bitxbio(TM), planned digital asset treasury, Pearsanta's planned IPO, and Evofem's plan to regain a national listing - MarketScreener
Aditxt Provides Updates On Its Growth Vision For Bitxbio™, Planned Digital Asset Treasury, Pearsanta’S Planned IPO, And Evofem’S Plan To Regain A National Listing - TradingView
Aditxt, Inc. SEC 10-Q Report - TradingView
Aditxt Proposes Name Change to bitXbio as Part of Blockchain Integration Strategy - citybuzz
[NT 10-Q] Aditxt, Inc. SEC Filing - Stock Titan
Visualizing Aditxt Inc. stock with heatmaps2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Is Aditxt Inc. stock safe for conservative investorsPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Will Aditxt Inc. stock see insider buyingJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
Can trapped investors hope for a rebound in Aditxt Inc.Trade Ideas & Scalable Portfolio Growth Methods - newser.com
How sustainable is Aditxt Inc. stock dividend payoutEarnings Risk Report & Step-by-Step Trade Execution Guides - newser.com
ADTX | Aditxt Inc. SEC Filings - MarketWatch
Will Aditxt Inc. stock deliver consistent dividends2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Can swing trading help recover from Aditxt Inc. losses2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Why Aditxt Inc. stock could rally in 20252025 Trade Ideas & Verified Stock Trade Ideas - Fundação Cultural do Pará
Is Aditxt Inc. stock vulnerable to regulatory risksJuly 2025 Recap & Advanced Technical Signal Analysis - newser.com
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - Benzinga
Building trade automation scripts for Aditxt Inc.July 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Why Aditxt Inc. stock remains undervaluedWeekly Trade Recap & Free High Return Stock Watch Alerts - newser.com
Price action breakdown for Aditxt Inc.Market Volume Summary & Short-Term Trading Opportunity Alerts - newser.com
Momentum divergence signals in Aditxt Inc. chartWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
How rising interest rates impact Aditxt Inc. stock2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Will Aditxt Inc. stock deliver better than expected guidanceJuly 2025 Update & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):